Favipiravir Effects on the Control of Clinical Symptoms of Hospitalized COVID-19 Cases: An Experience with Iranian Formulated Dosage Form

Coronavirus disease -19 (COVID-19) pandemic, caused by SARS-CoV-2, has gradually spread worldwide, becoming a major public health event. This situation requires designing a novel antiviral agent against the SARS-CoV-2; however, this is time-consuming and the use of repurposed medicines may be promis...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabarsi, Payam, Vahidi, Hossein, Saffaei, Ali, Hashemian, Seyed Mohammad Reza, Jammati, Hamidreza, Daraei, Bahram, Mahboubi, Arash, Kobarfard, Farzad, Marjani, Majid, Moniri, Afshin, Abtahian, Zahra, Abedini, Atefeh, Eslaminejad, Alireza, Heshmatnia, Jalal, Mirenayat, Maryam Sadat, Fakharian, Atefeh, Seifi, Sharareh, Sadeghi, Mohsen, Dastan, Alireza, Haseli, Sara, Nadji, Seyed Alireza, Eskandari, Raha, Yousefian, Sahar, Varahram, Mohammad, Zali, Alireza, Velayati, Ali Akbar, Dastan, Farzaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842610/
https://www.ncbi.nlm.nih.gov/pubmed/35194422
http://dx.doi.org/10.22037/ijpr.2021.115510.15401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842610/
https://www.ncbi.nlm.nih.gov/pubmed/35194422
http://dx.doi.org/10.22037/ijpr.2021.115510.15401

Ejemplares similares